Trump recently attacked Fed rates and even talked about trying to gain more control over the independent body.
The injectables business of Claris Lifesciences comprises 70.0%–80.0% of its total sales. Claris plans to repatriate about 85.0% of the generated funds to its shareholders.
Claris Injectables’ portfolio is expected to complement Baxter’s leading presence in the renal and hospital products segment.
Through the acquisition of Claris Injectables, Baxter International aims to accelerate its strategy to become a leader in the global injectables market.
On December 15, 2016, Baxter International (BAX) announced the acquisition of Claris Injectables, a subsidiary of Claris Lifesciences, for $625.0 million.
On December 14, 2016, Air Products and Chemicals (APD) was trading at a one-year forward PE multiple of 22.6x, compared to Praxair’s (PX) one-year forward PE multiple of 20.8x.
Of the 21 brokerage firms that actively track Air Products and Chemicals (APD), ~52% of these analysts recommended a “buy” for the stock, 43% recommended a “hold,” and the remaining 5% recommended a “sell” for the stock.
For fiscal 2016, the dividend payout ratio for Air Products and Chemicals (APD) stood at ~47.6% compared to the dividend payout ratio of ~52.7%.
At the end of Air Products and Chemicals’s (APD) fiscal 2016, the company had gained ~15.5%. In this series, we’ll take a closer look at APD’s dividend announcement, its analyst recommendations, and its most recent valuations.
On December 15, 2016, FMC’s (FMC) board declared a fourth quarter dividend of $0.17 per share. The dividend will be paid on January 19, 2017.
In a strategic move on December 14, DuPont (DD) announced that Hygenia will acquire its global food safety diagnostics business.
3M (MMM) is in the process of realigning its portfolio to have a more customer-focused business model. It brought down its business portfolio from 40 to 25.
On December 14, 2016, Albemarle (ALB) announced the completion of the sale of its Chemetall surface treatment business to BASF.
On December 15, LyondellBasell was trading at a one-year forward PE ratio of 9.1x, which is at a discount compared to Eastman, Dow, and Celanese.
As of December 15, 2016, 16 brokerage firms are actively tracking LyondellBasell stock. About 35% of these analysts have recommended a “buy” for the stock.
On November 18, LyondellBasell (LYB) announced a fourth quarter dividend of $0.85 per share.
LyondellBasell (LYB) stock has made a strong comeback since it announced its 3Q16 earnings on November 1.
As of December 14, 2016, about 50.0% of the analysts tracking Albemarle stock have recommended a “buy” for the stock. The other 50.0% have recommended a “hold.”
As of December 14, 2016, Albemarle (ALB) was trading at a one-year forward PE multiple of 22.7x compared to W.R. Grace (GRA) at 20.0x.
In the first nine months of 2016, Albemarle has paid a dividend of $101.1 million, which represents a dividend payout ratio of approximately 25.9%.